Global Warts Treatment Market, By Strain Type (Verruca Vulgaris, Verruca Plana, and Others), Type (Common Warts, Plantar Warts, Flat Warts, and Others), Treatment (Physical Destruction, Chemical Destruction, Immunomodulation, and Others), Mode of Administration (Injectable, Oral, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), End User (Hospitals, Homecare, Specialty Clinics, and Others) – Industry Trends and Forecast to 2031.
Warts Treatment Market Analysis and Size
The warts treatment market is experiencing steady growth, driven by the increasing prevalence of HPV infections and the resultant rise in cases of warts globally. The Centers for Disease Control and Prevention (CDC) report that HPV causes genital warts in approximately 340,000 to 360,000 women and men in the U.S. each year. Consequently, the increasing prevalence of warts and HPV infections is fueling the growth of the warts treatment market. According to the CDC, anogenital warts frequently recur within three months. As the recurrence rate of warts rises, the demand for treatments and therapies also increases, further driving the warts treatment market. Factors such as heightened awareness about skin health, advancements in treatment options, and the growing adoption of minimally invasive procedures are fueling market expansion.
Global warts treatment market size was valued at USD 80 million in 2023 and is projected to reach USD 106 million by 2031, with a CAGR of 3.60% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Strain Type (Verruca Vulgaris, Verruca Plana, and Others), Type (Common Warts, Plantar Warts, Flat Warts, and Others), Treatment (Physical Destruction, Chemical Destruction, Immunomodulation, and Others), Mode of Administration (Injectable, Oral, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), End User (Hospitals, Homecare, Specialty Clinics, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America
|
|
Market Players Covered
|
Verrica Pharmaceuticals (U.S.), RXi Pharmaceuticals (US), Peritech Pharma (Israel), Euro Vital Pharma GmbH (Germany), Bausch Health (Canada), Dr. Reddy’s Laboratories Ltd (India), Nowarta Biopharma, Inc. (U.S.), Cutanea Life Sciences, Inc (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Warts treatment encompasses a variety of methods aimed at removing or reducing the appearance of warts, which are benign skin growths caused by the human papillomavirus (HPV). Treatment options vary based on the type, location, and severity of the warts, as well as the patient's overall health and preference.
Warts Treatment Market Dynamics
Drivers
- Increasing Prevalence of HPV Infections
HPV viruses, known for promoting the excessive growth of keratin on the skin's surface, lead to the formation of warts. As more individuals contract HPV, especially strains that cause warts, the need for accessible and efficient wart treatments becomes paramount. This trend underscores the importance of continued research, awareness campaigns, and innovative treatment approaches to address the growing burden of warts globally. The global rise in HPV infections is directly linked to an increased incidence of warts, thus driving the demand for effective treatment options.
- Advancements in Treatment Technologies
Recent advancements in wart treatment technologies have revolutionized the field by offering more effective and less invasive options for the most effective wart treatment. Treatments like cryotherapy, which involves freezing the wart, laser therapy that targets and destroys wart tissue, and immunotherapy which boosts the body's immune response against the virus, have significantly improved patient outcomes. Laser wart removal, a non-invasive procedure that uses targeted laser energy to precisely eliminate warts from the skin’s surface, ensures accurate targeting of warts while minimizing damage to surrounding healthy tissue. For instance, cutaneous plantar warts can be treated using various methods, and the use of laser surgery has increased in recent years. This study examined the efficacy of laser treatment combined with simple cooling to reduce pain, achieving a cure rate of approximately 84%. By integrating these advanced treatments, the wart treatment market continues to grow, providing patients with a broader array of effective and less invasive options.
Opportunities
- Government Initiatives and Public Health Campaigns
Public health campaigns aimed at educating the population about HPV transmission, the importance of vaccination, and early detection of warts can lead to a higher demand for treatment options. Additionally, government funding for research into new treatment modalities and initiatives to make existing treatments more accessible can further drive market growth. Increased government efforts to promote awareness about HPV and wart prevention, as well as funding for research and treatment, have the potential to significantly boost the market for wart treatments.
- Recurring Nature of Warts
The tendency of warts, especially anogenital warts, to recur frequently ensures a continuous demand for treatment products and therapies. Despite successful treatment, warts can reappear due to the persistent nature of the HPV virus. This recurring nature of warts ensures a steady market for treatments, as patients often require multiple rounds of therapy to fully eradicate the warts. This ongoing demand underscores the importance of swift treatment for warts and the need for research into long-term solutions to prevent wart recurrence.
Restraints/Challenges
- High Cost of Advanced Treatments
The high cost of advanced treatment options such as laser therapy and immunotherapy can be a significant barrier to access for many patients, limiting market growth. While these treatments offer higher efficacy and less invasiveness compared to traditional methods, their cost can be prohibitive for individuals without adequate insurance coverage or financial resources. This highlights the importance of developing cost-effective treatment options and improving access to care for all patients.
- Side Effects and Complications
Some wart treatments can lead to side effects or complications, which may deter patients from seeking these options and slow market growth. For instance, wart treatment cryotherapy can cause pain, blistering, or skin discoloration at the treatment site, while immunotherapy can lead to flu-like symptoms or skin reactions. These side effects, although usually temporary and minor, can affect patient satisfaction and willingness to undergo treatment. Additionally, in some cases, complications such as scarring or infection may occur, further complicating the treatment process and challenging the market growth.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In October 2022, Assiut University will initiate a clinical investigation to evaluate the effectiveness and safety of intralesional acyclovir versus intralesional Vitamin D3 for treating plantar warts
- In April 2021, Teva Pharmaceuticals introduced the initial generic version of Absorica (isotretinoin) capsules for severe and persistent nodular acne, including warts. Oral isotretinoin presents a viable treatment alternative for individuals with stubborn facial flat warts
Warts Treatment Market Scope
The market is segmented on the basis of strain type, type, treatment, mode of administration, distribution channel, and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Strain Type
- Verruca vulgaris
- Verruca plana
- Others
Type
- Common warts
- Plantar warts
- Flat warts
- Others
Treatment
- Physical destruction
- Chemical destruction
- Immunomodulation
- Others
Mode of Administration
- Injectable
- Oral
- Others
Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
End Users
- Hospitals
- Homecare
- Specialty clinics
- Others
Warts Treatment Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, strain type, type, treatment, mode of administration, distribution channel, and end users as referenced above.
The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America is expected to dominate the market due to increasing healthcare initiatives, a strong presence of major market players, rising cases of warts, and a growing number of research activities in the region.
Asia-Pacific is expected to witness significant growth during the forecast period due to government initiatives to promote awareness, expanding research activities, vast untapped markets, a large population pool, and increasing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Warts Treatment Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- Verrica Pharmaceuticals (U.S.)
- RXi Pharmaceuticals (U.S.)
- Peritech Pharma (Israel)
- Euro Vital Pharma GmbH (Germany)
- Bausch Health (Canada)
- Dr. Reddy’s Laboratories Ltd (India)
- Nowarta Biopharma, Inc. (U.S.)
- Cutanea Life Sciences, Inc (U.S.)
SKU-